Iovance Biotherapeutics, Inc. (IOVA) — Stock Price, Chart & Analysis
Iovance Biotherapeutics, Inc. (IOVA) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $2.87B. Over the past 52 weeks, IOVA has traded between $1.76 and $6.92. Iovance Biotherapeutics, Inc. does not currently pay a regular dividend. View the live IOVA chart, technical opinion, analyst ratings, fundamentals and latest news below.
Iovance Biotherapeutics, Inc. (IOVA) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $2.87B |
| EPS (TTM) | $-0.70 |
| 52-week high | $6.92 |
| 52-week low | $1.76 |
| Beta | 0.70 |
| Avg. volume | 15.81M |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently asked questions about Iovance Biotherapeutics, Inc. (IOVA)
How much does one share of Iovance Biotherapeutics, Inc. cost?
As of the latest update, one share of Iovance Biotherapeutics, Inc. (IOVA) trades at $100 (+0.00% today).
What is Iovance Biotherapeutics, Inc.'s market cap?
Iovance Biotherapeutics, Inc. has a market capitalization of approximately $2.87B.
What is Iovance Biotherapeutics, Inc.'s earnings per share (EPS)?
Iovance Biotherapeutics, Inc.'s trailing twelve-month EPS is $-0.70.
Does Iovance Biotherapeutics, Inc. pay a dividend?
Iovance Biotherapeutics, Inc. does not currently pay a regular dividend.
What is Iovance Biotherapeutics, Inc.'s 52-week trading range?
Over the past year, IOVA has traded between $1.76 and $6.92.
What is the analyst price target for Iovance Biotherapeutics, Inc.?
The mean analyst price target for Iovance Biotherapeutics, Inc. is $9.00. This is informational only and not investment advice.
Latest Iovance Biotherapeutics, Inc. (IOVA) news
- Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling.News · Aug 7, 2026
- Does Iovance Biotherapeutics (IOVA) Have the Potential to Rally 28.02% as Wall Street Analysts Expect?News · Aug 7, 2026
- IOVA Q2 Earnings Beat, Stock Jumps 43% on Strong Amtagvi UptakeNews · Aug 7, 2026
- Why Did IOVA, REPL, ROKU Stocks Surge To 52-Week Highs Today?News · Aug 7, 2026
- Iovance Biotherapeutics Inc (IOVA) (Q2 2026) Earnings Call Highlights: Record Revenue and ...News · Aug 6, 2026
- Iovance Biotherapeutics (IOVA) Pops 43% on Stellar Q2. Here’s What Comes NextNews · Aug 6, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live IOVA dashboard…